Three Motley Rice attorneys were recognized as 2018 Connecticut Super Lawyers® and Rising Stars.
A California appellate panel ordered that claims alleging pancreatic cancer caused by diabetes drug manufacturers Merck & Co., Eli Lilly & Co., AstraZeneca’s Amylin Pharmaceuticals, and Novo Nordisk Inc., should move forward in state court.
U.S. District Judge Manish S. Shah appointed antitrust attorney Michelle Clerkin to the Plaintiffs’ Steering Committee for Volatility Index (VIX) multidistrict litigation.
Six Motley Rice attorneys are 2018 Rhode Island and New York Metro Super Lawyers® and Rising Stars.